Retour
Fourchette du Jour
22,25 €
23,10 €
Fourchette 52 Semaines
13,74 €
70,43 €
Volume
18 903 675
Moyenne 50J / 200J
23,15 €
/
41,39 €
Clôture Précédente
22,02 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 38,4 | 0,4 |
| P/B | 9,1 | 2,9 |
| ROE % | 25,2 | 3,7 |
| Net Margin % | 5,5 | 3,8 |
| Rev Growth 5Y % | 71,4 | 10,0 |
| D/E | 2,3 | 0,2 |
Points Clés
Revenue grew 71,42% annually over 5 years — strong growth
ROE of 25,23% indicates high profitability
Debt/Equity of 2,34 — high leverage
Generating 73,96M in free cash flow
P/E of 38,42 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,42%
Croissance
Revenue Growth (5Y)
71,42%
Revenue (1Y)59,00%
Earnings (1Y)1,85%
FCF Growth (3Y)25,46%
Qualité
Return on Equity
25,23%
ROIC5,06%
Net Margin5,47%
Op. Margin5,18%
Sécurité
Debt / Equity
2,34
Current Ratio1,90
Interest Coverage0,00
Valorisation
P/E Ratio
38,42
P/B Ratio9,12
EV/EBITDA49,03
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 59,00% | Revenue Growth (3Y) | 64,08% |
| Earnings Growth (1Y) | 1,85% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 71,42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,35B | Net Income (TTM) | 128,37M |
| ROE | 25,23% | ROA | 5,96% |
| Gross Margin | 59,31% | Operating Margin | 5,18% |
| Net Margin | 5,47% | Free Cash Flow (TTM) | 73,96M |
| ROIC | 5,06% | FCF Growth (3Y) | 25,46% |
| Safety | |||
| Debt / Equity | 2,34 | Current Ratio | 1,90 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 38,42 | P/B Ratio | 9,12 |
| P/S Ratio | 2,10 | PEG Ratio | -33,00 |
| EV/EBITDA | 49,03 | Dividend Yield | 0,00% |
| Market Cap | 4,93B | Enterprise Value | 5,97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,35B | 1,48B | 872,00M | 526,92M | 271,88M |
| Net Income | 128,37M | 126,04M | -23,55M | -65,68M | -107,66M |
| EPS (Diluted) | 0,51 | 0,53 | -0,11 | -0,32 | -0,58 |
| Gross Profit | 1,39B | 1,17B | 714,95M | 408,72M | 204,49M |
| Operating Income | 121,69M | 61,90M | -29,45M | -68,70M | -115,04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,15B | 707,54M | 441,19M | 366,34M | 420,59M |
| Total Liabilities | 1,61B | 230,82M | 97,16M | 54,60M | 85,97M |
| Shareholders' Equity | 540,93M | 476,72M | 344,03M | 311,74M | 334,62M |
| Total Debt | 1,26B | 11,35M | 9,95M | 5,31M | 5,48M |
| Cash & Equivalents | 228,62M | 220,58M | 96,66M | 46,77M | 71,78M |
| Current Assets | 767,64M | 395,83M | 265,05M | 216,60M | 269,91M |
| Current Liabilities | 404,43M | 221,37M | 88,47M | 47,94M | 79,22M |